Effects of Diet Manipulation on Women in the Curves Program (Curves2)

March 22, 2017 updated by: Texas A&M University

Effects of a Carbohydrate Restricted, High Protein, High Fat Diet on Weight Loss and Health Outcomes in Women Participating in the Curves Fitness and Weight Loss Program

The purpose of this study is to look at the effects of a carbohydrate restricted, high protein, high fat diet on weight loss and health outcomes in women participating in the Curves Fitness and Weight Loss Program.

Study Overview

Detailed Description

The purpose of this study is to determine if a carbohydrate restricted, high protein, high fat diet (20% carbohydrate, 45% protein, 35% fat; CC-II) promotes more favorable changes in weight loss and health outcomes compared to a traditional high carbohydrate, low protein, low fat diet (55% carbohydrate, 15% protein, 30% fat; AHA) and the Curves moderate carbohydrate restricted, high protein, and low fat diet (30% carbohydrate, 45% protein, 25% fat; CC-I).

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • The participant is an apparently healthy female
  • The participant is between the ages of 18 and 60

Exclusion Criteria:

  • The participant is pregnant or nursing, or plans to become pregnant during the next 12 months or has been pregnant in the past 12 months
  • The participant has uncontrolled metabolic disorder including known electrolyte abnormalities; heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism; a history of hypertension, hepatorenal, musculoskeletal, autoimmune, or neurological disease
  • The participant is currently taking thyroid, hyperlipidemic, hypoglycemic, anti-hypertensive, or androgenic medications
  • The participant has taken ergogenic levels of nutritional supplements that may affect muscle mass (e.g., creatine, HMB), anabolic/catabolic hormone levels (androstenedione, DHEA, etc.) or weight loss (e.g., ephedra, thermogenics, etc.) within the past three months
  • The participant is willing to participate in a regular moderate exercise program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
(no diet or exercise intervention)
Experimental: American Heart Association
(AHA: 55% carbohydrate, 15% protein, 30% fat - diet plus exercise)
Active Comparator: Curves Complete - I
(CC - I: 30% carbohydrate, 45% protein, 25% fat - diet plus exercise)
Active Comparator: Curves Complete - II
(CC - II: 20% carbohydrate, 45% protein, 35% fat - diet plus exercise)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Effects of the Curves program on physical activity patterns
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on body weight
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on the hip/waist ratio
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on Resting Energy Expenditure (REE)
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on Blood Pressure (BP)
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on Heart Rate (HR)
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on body composition (DXA)
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on Bioelectrical Impedance Analysis (BIA)
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on a chemistry-15 blood panel
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on a cell blood count (CBC) blood panel
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on lipid panels
Time Frame: 24 weeks
24 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Effects of the Curves program on maximal cardiopulmonary capacity
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on muscular strength through a 1 repetition maximum (1 RM) test
Time Frame: 24 weeks
24 weeks
Effects of the Curves program on muscular endurance through a maximal repetition test
Time Frame: 24 weeks
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Richard B Kreider, PhD, Texas A&M University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2013

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

March 22, 2017

First Submitted That Met QC Criteria

March 22, 2017

First Posted (Actual)

March 28, 2017

Study Record Updates

Last Update Posted (Actual)

March 28, 2017

Last Update Submitted That Met QC Criteria

March 22, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • IRB2013-0495FX

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diet, Carbohydrate-Restricted

Clinical Trials on Control

3
Subscribe